MBP and myeloid sarcoma: Multiple studies have demonstrated that autoantibodies for MBP, a multifunctional protein that composes a significant portion of CNS myelin protein, can reliably be detected in the CSF of patients diagnosed with MS, while only 2% of samples amongst non-MS controls had MBP autoantibodies [118,119,120,121].